These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18281470)

  • 1. Fc gamma RIIIa expression is not increased on natural killer cells expressing the Fc gamma RIIIa-158V allotype.
    Congy-Jolivet N; Bolzec A; Ternant D; Ohresser M; Watier H; Thibault G
    Cancer Res; 2008 Feb; 68(4):976-80. PubMed ID: 18281470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.
    Dall'Ozzo S; Tartas S; Paintaud G; Cartron G; Colombat P; Bardos P; Watier H; Thibault G
    Cancer Res; 2004 Jul; 64(13):4664-9. PubMed ID: 15231679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding.
    Edberg JC; Kimberly RP
    J Immunol; 1997 Oct; 159(8):3849-57. PubMed ID: 9378972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa.
    de Haas M; Koene HR; Kleijer M; de Vries E; Simsek S; van Tol MJ; Roos D; von dem Borne AE
    J Immunol; 1996 Apr; 156(8):2948-55. PubMed ID: 8609432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
    Galatiuc C; Gherman M; Metes D; Sulica A; DeLeo A; Whiteside TL; Herberman RB
    Cell Immunol; 1995 Jul; 163(2):167-77. PubMed ID: 7606790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells.
    Bowles JA; Weiner GJ
    J Immunol Methods; 2005 Sep; 304(1-2):88-99. PubMed ID: 16109421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent effects of Fc gamma RIIIA ligands on the functional activities of human natural killer cells in vitro.
    Sulica A; Metes D; Gherman M; Whiteside TL; Herberman RB
    Eur J Immunol; 1996 Jun; 26(6):1199-203. PubMed ID: 8647192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C.
    Borrego F; Lopez-Beltran A; Peña J; Solana R
    Cell Immunol; 1994 Oct; 158(1):208-17. PubMed ID: 8087866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the Fc{gamma}RIIIa-158 V/V and V/F polymorphism.
    Hatjiharissi E; Xu L; Santos DD; Hunter ZR; Ciccarelli BT; Verselis S; Modica M; Cao Y; Manning RJ; Leleu X; Dimmock EA; Kortsaris A; Mitsiades C; Anderson KC; Fox EA; Treon SP
    Blood; 2007 Oct; 110(7):2561-4. PubMed ID: 17475906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent phosphotyrosine signaling via Fc gamma RIIIA on human NK cells.
    Manciulea M; Rabinowich H; Sulica A; Lin WC; Whiteside TL; DeLeo A; Herberman RB; Corey SJ
    Cell Immunol; 1996 Jan; 167(1):63-71. PubMed ID: 8548846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of human immunoglobulin G with CD16 on natural killer cells: ligand clearance, FcgammaRIIIA turnover and effects of metalloproteinases on FcgammaRIIIA-mediated binding, signal transduction and killing.
    Mota G; Moldovan I; Calugaru A; Hirt M; Kozma E; Galatiuc C; Brasoveanu L; Boltz-Nitulescu G
    Scand J Immunol; 2004 Mar; 59(3):278-84. PubMed ID: 15030579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Fc gamma RIIIa is present in plasma and is derived from natural killer cells.
    de Haas M; Kleijer M; Minchinton RM; Roos D; von dem Borne AE
    J Immunol; 1994 Jan; 152(2):900-7. PubMed ID: 8283059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cells.
    Vance BA; Huizinga TW; Wardwell K; Guyre PM
    J Immunol; 1993 Dec; 151(11):6429-39. PubMed ID: 8245476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Fc gamma RIII (CD16). Isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells.
    Edberg JC; Redecha PB; Salmon JE; Kimberly RP
    J Immunol; 1989 Sep; 143(5):1642-9. PubMed ID: 2474607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of Fc gamma RII on human natural killer cells.
    Metes D; Galatiuc C; Moldovan I; Morel PA; Chambers WH; DeLeo AB; Rabinowich H; Schall R; Whiteside TL; Sulica A
    Nat Immun; 1994; 13(6):289-300. PubMed ID: 7894200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding.
    Tamm A; Schmidt RE
    J Immunol; 1996 Aug; 157(4):1576-81. PubMed ID: 8759741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.
    Jewett A; Teruel A; Romero M; Head C; Cacalano N
    Cancer Immunol Immunother; 2008 Jul; 57(7):1053-66. PubMed ID: 18188563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors for the Fc fragment of IgG on natural killer cells.
    Trinchieri G; Valiante N
    Nat Immun; 1993; 12(4-5):218-34. PubMed ID: 8257828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric assay for determination of FcgammaRIIIA-158 V/F polymorphism.
    Böttcher S; Ritgen M; Brüggemann M; Raff T; Lüschen S; Humpe A; Kneba M; Pott C
    J Immunol Methods; 2005 Nov; 306(1-2):128-36. PubMed ID: 16181633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of Fc gamma RIIIa-158V-F polymorphism to recurrence of adult periodontitis in Japanese patients.
    Sugita N; Yamamoto K; Kobayashi T; Van Der Pol W; Horigome T; Yoshie H; Van De Winkel JG; Hara K
    Clin Exp Immunol; 1999 Aug; 117(2):350-4. PubMed ID: 10444269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.